The workflow integrates multistep 0D (single-cell), 1D and 2D model simulations in a single automated process. by Pei-Chi Yang (253977)

Table_1_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.xlsx by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_7_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_8_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_1_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_3_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_4_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_6_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

Image_2_Rice OseIF6.1 encodes a eukaryotic translation initiation factor and is essential for the development of grain and anther.jpeg by Hongming Guo (13166058)

“…Here, we characterized the functions of OseIF6.1, which is homologous to At-eIF6;1. OseIF6.1 encodes an eukaryotic translation initiation factor with a conserved eIF6 domain. …”

ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota by Sup Kim (6371849)

“…</p> <p><b>Abbreviations:</b> ABX, antibotics; AMPK, AMP-activated protein kinase; ATP5A1, ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; BECN1, beclin1, autophagy related, CCL, C-C motif chemokine ligand; CD, Crohn disease; CLDN, claudin; COX4I1, cytochrome c oxidase subunit 4I1; cKO, conditional knockout; cWT, conditional wild-type; CXCL, C-X-C motif chemokine ligand; DAI, disease activity index; DSS, dextran sodium sulfate; EGFP, enhanced green fluorescent protein; ESRR, estrogen related receptor; ESRRA, estrogen related receptor alpha; Esrra+/+, Esrra wild type; esrra–/-, esrra homozygous knockout; FMT, fecal microbiota transplantation; GABARAP, gamma-aminobutyric acid receptor associated protein; GSEA, gene set enrichment analysis; IBD, inflammatory bowel disease; IL, interleukin; KO, knockout; LAMP1, lysosomal-associated membrane protein 1; LCN2, lipocalin 2; LEfSe, linear discriminant analysis (LDA) effect size; LPS, lipopolysachharide; MAP1LC3/LC3, microtubule associated protein 1 light chain 3; NDUFAB1, NADH: ubiquinone oxidoreductase subunit AB1; OCLN, occludin; OUT, operational taxonomic unit; OXPHOS, oxidative phosphorylation; PCoA, principal coordinate analysis; PPARGC1A, PPARG coactiva- tor 1 alpha; PRKAA, 5’-AMP-activated protein kinase catalytic subunit alpha; PTGS2/COX2, prostaglandin-endoperoxide synthase 2; RAB7, member RAS oncogene family; SDHB, succinate dehydrogenase complex, subunit B, iron sulfur (Ip); SQSTM1/p62, sequestosome 1; S100A9, S100 calcium binding protein A9 (calgranulin B); TCA, tricarboxylic acid; TFEB, transcription factor EB; TNF, tumor necrosis factor; UC, ulcerative colitis; UCP2, uncoupling protein 2 (mitochondrial, proton carrier); UQCRC1, ubiquinol-cytochrome c reductase core protein 1; UVRAG, UV radiation resistance associated gene; Vil1, villin; VPS11, VPS11, CORVET/HOPS core sub-unit; WT, wild type.…”

ACE phenotype for carriers of ACE mutations. by Olga V. Kryukova (19819428)

Localization of tested ACE mutations in the N and C domains of ACE. by Olga V. Kryukova (19819428)

Table1_Xinmailong injection on left ventricular remodeling and inflammatory mediators in patients with CHF: a systematic review and meta-analysis.DOCX by Xu Han (141301)

“…</p>Result:<p>Compared with conventional treatment (CT), the combination therapy of XMLI and CT significantly improved LVR and reduced inflammatory mediators, mainly manifested by an increase in LVEF (MD = 6.40, 95% CI: 5.25 to 7.55, p = 0.000), a decrease in LVEDD (MD = −4.63, 95% CI: −5.69 to −3.57, p = 0.000) and LVESD (MD = −4.00, 95% CI: −5.50 to −2.50, p = 0.000), as well as a decrease in TNF-α (MD = −7.93, 95% CI: −9.86 to −6.00, p = 0.000), IL-6 (MD = −5.25, 95% CI: −6.59 to −3.92, p = 0.000), IL-18 (MD = −36.07, 95% CI: −46.76 to −25.38, p = 0.000), CRP (MD = −4.41, 95% CI: −6.40 to −2.42, p = 0.000), hs-CRP (MD = −4.90, 95% CI: −5.71 to −4.08, p = 0.000), and an increase in IL-10 (MD = 20.19, 95% CI: 10.42 to 29.97, p = 0.000). …”

Table_2_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…Background<p>With the successful implementation of the Surviving Sepsis Campaign guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who acutely survive surgical sepsis will either rapidly recover or develop a chronic critical illness (CCI). …”

Table_3_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…Background<p>With the successful implementation of the Surviving Sepsis Campaign guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who acutely survive surgical sepsis will either rapidly recover or develop a chronic critical illness (CCI). …”

Table_1_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…Background<p>With the successful implementation of the Surviving Sepsis Campaign guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who acutely survive surgical sepsis will either rapidly recover or develop a chronic critical illness (CCI). …”

Table_7_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…Background<p>With the successful implementation of the Surviving Sepsis Campaign guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who acutely survive surgical sepsis will either rapidly recover or develop a chronic critical illness (CCI). …”

Table_6_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…Background<p>With the successful implementation of the Surviving Sepsis Campaign guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who acutely survive surgical sepsis will either rapidly recover or develop a chronic critical illness (CCI). …”

Table_4_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…Background<p>With the successful implementation of the Surviving Sepsis Campaign guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who acutely survive surgical sepsis will either rapidly recover or develop a chronic critical illness (CCI). …”

Global, regional and national burden of colorectal cancer and its risk factors, 1990-2021: a systematic analysis for the GBD 2021 by Xuan Zeng (22461799)